2020-2021 Biomedical Sciences Options - Course Details
2020-2021 Biomedical Sciences Options - Course Details
2020-2021 Biomedical Sciences Options - Course Details
Page 1
Biomedical Sciences Options – 2020-2021, Semester 2
Title: BIOL5199 – Current Trends and Challenges in Biomed Research & Health
Credits 10
Course Coordinator: Dr Kirsty Hacking
Course Duration: 3 Weeks (Weeks 29-31)
Programmes Applicable
Course Description
During this course students will select a current topical issue in biomedical research or health, and working in
small groups, will critically research the topic, develop a plan to address the challenge, and present their
research and conclusions as a poster.
Course Aims
The course aims to provide students with an opportunity to research a current topical issue or challenge of
their choice in biomedical research or health. Students will select an area of recent global or national
importance, and working in groups, will plan and perform research of the scientific background of the issue,
analysing and synthesising the available information to draw conclusions, and/or develop possible solutions
to the issue.
Intended Learning Outcomes
By the end of this course, students will be able to:
• select and critically investigate a current topical issue or challenge in biomedical research or health;
• critically analyse, evaluate and summarise the literature and other factual information on the
current topical issue or challenge;
• develop and appraise solutions to resolve, control or contain the current challenge, or explanatory
hypotheses and plans for further research, as appropriate to the topic chosen;
• summarise and present their conclusions in poster form in a style appropriate for a target audience
of stakeholders, end-users or the general public;
• work effectively in autonomous groups, and reflect critically on their role and performance within
the group
Course Summative Assessment
• Students are assessed individually with a reflective portfolio, summarising their participation and
contribution to the group work, and an assessment of the skills developed during the course (30%).
• Each group of students is assessed through a poster showing the results of their research, and their
solutions to resolve, control or contain the current challenge, or explanatory hypotheses and plans
for further research, as appropriate to the topic chosen. The poster will be aimed at a specific and
appropriate target audience (e.g. stakeholders, public health officials, general public) (70%). A group
mark will be awarded for the poster that is the same for all students in the group.
Co-requisites/Excluded Courses
None
Page 2
Biomedical Sciences Options – 2020-2021, Semester 2
Page 3
Biomedical Sciences Options – 2020-21, Semester 2
Title: BIOL5354 – Bioinformatics using R for Biologists
Credits: 10
Course Coordinator: Dr Kirsty Hacking/Dr John Cole
Course Duration: 3 Weeks (29-31)
Programmes Applicable
Course Description
This course will provide life sciences students with an introduction and practice in bioinformatic data
analysis with a focus on programming in R.
Course Aims
This course aims to introduce students to bioinformatic data processing with a focus on R programming,
using a common package and statistical analysis. This course will introduce the basics of cleaning data and
the general qualities of small/big, and low/high dimensional data. This course will provide practice in using
these methods to provide a foundation understanding for future project and industry placements
Intended Learning Outcomes
By the end of this course, students will be able to:
• Demonstrate fundamental principles of coding in R, with particular focus on manipulating large files,
statistical analysis and generating plots.
• Demonstrate a critical awareness of how omic and clinical datasets are generated, processed, quality
controlled, cleaned and corrected.
• Critically explore and communicate the biological results from big and high dimensional datasets
using statistics and visualisation techniques appropriate to their own field.
• Critically appraise omic and/or clinical data of a type that is now ubiquitous in biological research.
• Critically assess the role of bioinformatics in their own field
Course Summative Assessment
Page 4
Biomedical Sciences Options – 2020-21, Semester 2
Title: BIOL5346 – Introduction to Next Generation Sequencing Bioinformatics
Credits: 10
Course Coordinator: Dr Thomas Otto
Course Duration: 3 Weeks (32-34)
Programmes Applicable
Course Description
This course will provide students with a holistic understanding of bioinformatics and how it can be used to
analysis next generation sequencing data. The learnt skills will provide a good understand for future dry lab
project or to understand bioinformatics analysis. Also, the learnt skill set will be transferable, e.g.
visualization and abstraction of data.
Course Aims
The aim of this programme is to introduce the concepts of bioinformatics and give participants the
opportunity to understand and undertake next generation sequencing analysis
Intended Learning Outcomes
By the end of this course, students will be able to:
• Critically explain the use bioinformatics in life sciences
• Use of command line tools (Linux / R) to perform bioinformatics analysis
• Critically evaluate the step of quality control in next generation sequencing experiments
• Critically understand the visualization possibilities of next generation sequencing results
• Evaluate approaches to analysis genomic and transcriptomic experiments
• Critically discuss bioinformatics analysis in scientific publication
Course Summative Assessment
• Set exercise with short discussion of a genomic NGS dataset. Write up should be screenshots and a
short (100-500 words) discussion on the main findings. (33%.)
• Analysis of transcriptomics NGS data in Linux and R. Students need to quality control the NGS data,
map them in Linux, analysis them in R in two different manners and finally discuss the results by
comparing the results to data presented in the lectures. Write up can be screenshots (with short
description) of the different steps and around 500-1000 words to discuss the findings. (66%)
Page 5
Biomedical Sciences Options – 2020-21, Semester 2
Title: BIOL5200 – Technology Transfer & Commercialisation of Bioscience Research
Credits: 10
Course Coordinator: Dr Elaine Huston
Course Duration: 3 Weeks (32-34)
Programmes Applicable
Course Description
During this course, students will evaluate the technology transfer of bioscience research and the
commercialisation of research ideas. Working in small groups, they will design and evaluate a market
research strategy and business plan for a small company planning to commercialise a recent bioscience
discovery.
Course Aims
This course aims to provide students with an opportunity to assess the nature of businesses based on
bioscience knowledge and research, their opportunities for innovation, and constraints related to regulatory
requirements, intellectual property and ethical issues and the market. Students will study a range of
biotechnology industry topics in depth, including the fundamental concepts of business structures, business
plans and models related to the biotechnology industry. In addition, they will evaluate the ethical, legal,
professional, and social issues raised by biotechnology.
Intended Learning Outcomes
By the end of this course, students will be able to:
• critically analyse and evaluate the fundamental concepts of business structures, business plans and
models related to the biotechnology industry;
• design and critically evaluate a market research strategy for a small company planning to
commercialise a recent bioscience discovery;
• draft a business plan for a small company involved in the commercialisation of a recent bioscience
discovery, including appropriate SWOT (strengths, weaknesses, opportunities & threats) and PEEST
(political, environmental, economic, societal, technical) analysis;
• evaluate and analyse data relating to the biotechnology industry and present research findings in the
form of written reports;
• summarise and present clear, well-constructed oral presentations and written reports on areas of
the biotechnology industry and specific biotechnology companies.
Course Summative Assessment
Page 6
Biomedical Sciences Options – 2019-2020, Semester 2
Title: BIOL5291 – Neuroinflammation in Health & Disease
Credits: 10
Course Coordinator: Prof Jonathan Cavanagh
Course Duration: 3 Weeks (32-34)
Programmes Applicable
Page 7
Biomedical Sciences Options – 2019-2020, Semester 2
Title: BIOL5314 – Emerging Viruses
Credits: 10
Course Coordinator: Dr Sam Wilson
Course Duration: 3 Weeks (32-34)
Programmes Applicable
Page 8
Biomedical Sciences Options – 2019-2020, Semester 2
Title: BIOL5197 – Omic Analyses for the Biomedical Sciences: From Genomics to Metabolomic
Credits: 20
Course Coordinator: Dr Richard Burchmore
Course Duration: 5 Weeks (35-39)
Programmes Applicable
Page 9
Biomedical Sciences Options – 2020-2021, Semester 2
Page 10
Biomedical Sciences Options – 2020-2021, Semester 2
Title: BIOL5312 – Plant Biotechnology
Credits: 20
Course Coordinator: Dr Joel Milner
Course Duration: 5 Weeks (35-39)
Programmes Applicable
Page 11
Biomedical Sciences Options – 2020-2021, Semester 2
Title: MED5425 – Clinical Genomics
Credits: 20
Course Coordinator: Prof Ed Tobias
Course Duration: 5 Weeks (35-39)
Programmes Applicable
• MSc in Genetic and Genomic Counselling • MSc Cancer Research and Precision Oncology
(compulsory) • MSc Biomedical Sciences
• MSc in Medical Genetics (option)
Course Description
This course will provide an overview of the clinical applications of genomic approaches to human disorders, particularly
in relation to clinical genetics, discussing the methods and capabilities of the new technologies. Tuition and hands-on
experience in data analysis will be provided, including the interpretation of next generation sequencing reports.
Course Aims
The aims of this course are to facilitate an understanding of the following topics:
• Structure and function of the human genome (e.g. enhancers, epigenetics, chromatin remodelling, non-coding
regions and the ENCODE project)
• Diagnostic analysis of the human genome (and exome and genome sequencing) – standard and high-
throughput technologies
• Clinical bioinformatics - making sense of the data (“PHREDs, PEDs and BEDs”), with practical hands-on
experience in data analysis and evaluating the pathogenicity of single nucleotide variants (SNVs).
• Terminology (e.g. PHRED scores, PED and BED files, BAM files, CRAM files, BCFs, VCFs, SNVs, CNVs, and many
more)
• Ethical aspects of whole genome analysis (including incidental findings)
• Stratified medicine & pharmacogenomics.
Page 12
Biomedical Sciences Options – 2020-2021, Semester 2
Page 13